Literature DB >> 22311014

Cytomegalovirus infection and coronary heart disease risk: a meta-analysis.

Ya-Nan Ji1, Li An, Ping Zhan, Xiao-Hu Chen.   

Abstract

The chronic inflammatory process including cytomegalovirus (CMV) infection has been hypothesized to induce the progression of atherosclerosis in coronary heart disease (CHD). Numbers studies were conducted to analyze the association between CMV infection and risk of CHD, but no clear consensus had been reached. To assess this relationship more precisely, a meta-analysis was performed. The electronic databases PubMed, Embase, and CNKI were searched; data were extracted and analyzed independently by two investigators. Ultimately, 55 studies, involving 9,000 cases and 8,608 controls from six prospective studies (all with a nested case-control design) and 49 retrospective case-control studies were included. Overall, people exposed to CMV infection had an odds ratio (OR) of 1.67 (95% CI, 1.56-1.79) for CHD risk, relative to those not exposed. CMV infection was clearly identified as a risk factor for CHD in both prospective studies (OR, 1.31; 95% CI, 1.132-1.517) and retrospective studies (OR, 1.79; 95% CI, 1.659-1.939), and in both Asian group (OR, 2.69; 95% CI, 2.304-3.144) and non-Asian group (OR, 1.48; 95% CI, 1.371-1.600). Interestingly, in the subgroup analyses by detection methods of CMV, the increased risk (OR, 8.121) was greater among studies using polymerase chain reaction than the risk (OR, 1.561) among studies using enzyme-linked immunosorbent assay. In conclusion, this meta-analysis suggested that CMV infection is associated with an increased risk for CHD, especially among Asian populations.

Entities:  

Mesh:

Year:  2012        PMID: 22311014     DOI: 10.1007/s11033-012-1482-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  52 in total

1.  Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; B K Butland; P M Sweetnam; P C Elwood
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

2.  Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile.

Authors:  A Hoffmeister; D Rothenbacher; G Bode; K Persson; W März; M A Nauck; H Brenner; V Hombach; W Koenig
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-03       Impact factor: 8.311

3.  Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease.

Authors:  M Smieja; L Cronin; M Levine; C H Goldsmith; S Yusuf; J B Mahony
Journal:  Can J Cardiol       Date:  2001-03       Impact factor: 5.223

4.  Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis.

Authors:  S P Adler; J K Hur; J B Wang; G W Vetrovec
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

5.  Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.

Authors:  J Sheehan; P M Kearney; S O Sullivan; C Mongan; E Kelly; I J Perry
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

6.  Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not.

Authors:  J M Ossewaarde; E J Feskens; A De Vries; C E Vallinga; D Kromhout
Journal:  Epidemiol Infect       Date:  1998-02       Impact factor: 2.451

7.  Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall.

Authors:  Y F Zhou; M Shou; E Guetta; R Guzman; E F Unger; Z X Yu; J Zhang; T Finkel; S E Epstein
Journal:  Circulation       Date:  1999-10-05       Impact factor: 29.690

Review 8.  Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation.

Authors:  Thomas J DeGraba
Journal:  Stroke       Date:  2004-10-07       Impact factor: 7.914

9.  Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.

Authors:  Jean Louis Georges; Hans J Rupprecht; Stefan Blankenberg; Odette Poirier; Christoph Bickel; Gerd Hafner; Viviane Nicaud; Jürgen Meyer; François Cambien; Laurence Tiret
Journal:  Am J Cardiol       Date:  2003-09-01       Impact factor: 2.778

10.  Active cytomegalovirus replication in patients with coronary disease.

Authors:  Sara Gredmark; Lena Jonasson; Djoke Van Gosliga; Jan Ernerudh; Cecilia Söderberg-Nauclér
Journal:  Scand Cardiovasc J       Date:  2007-08       Impact factor: 1.589

View more
  27 in total

Review 1.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Authors:  Allison E Aiello; Yen-Ling Chiu; Daniela Frasca
Journal:  Geroscience       Date:  2017-06-18       Impact factor: 7.713

3.  Productive Cytomegalovirus Infection Is Associated With Impaired Endothelial Function in ST-Elevation Myocardial Infarction.

Authors:  Anna Lebedeva; Elena Maryukhnich; Jean-Charles Grivel; Elena Vasilieva; Leonid Margolis; Alexander Shpektor
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

4.  Genetic manipulation of the ApoF/Stat2 locus supports an important role for type I interferon signaling in atherosclerosis.

Authors:  William R Lagor; David W Fields; Robert C Bauer; Alison Crawford; Michael C Abt; David Artis; E John Wherry; Daniel J Rader
Journal:  Atherosclerosis       Date:  2014-01-10       Impact factor: 5.162

Review 5.  'From immunosenescence to immune modulation': a re-appraisal of the role of cytomegalovirus as major regulator of human immune function.

Authors:  Paul Moss
Journal:  Med Microbiol Immunol       Date:  2019-05-03       Impact factor: 3.402

Review 6.  Infectious burden and atherosclerosis: A clinical issue.

Authors:  Rosa Sessa; Marisa Di Pietro; Simone Filardo; Ombretta Turriziani
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

Review 7.  CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity.

Authors:  Eugenia Corrales-Aguilar; Katja Hoffmann; Hartmut Hengel
Journal:  Semin Immunopathol       Date:  2014-10-07       Impact factor: 9.623

Review 8.  Infectious and coronary artery disease.

Authors:  Mohammad Saeid Rezaee-Zavareh; Mohammad Tohidi; Amin Sabouri; Mahdi Ramezani-Binabaj; Mohsen Sadeghi-Ghahrodi; Behzad Einollahi
Journal:  ARYA Atheroscler       Date:  2016-01

Review 9.  Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.

Authors:  Mitchell S V Elkind; Amelia K Boehme; Craig J Smith; Andreas Meisel; Marion S Buckwalter
Journal:  Stroke       Date:  2020-09-08       Impact factor: 7.914

Review 10.  Human cytomegalovirus and autoimmune disease.

Authors:  Anne Halenius; Hartmut Hengel
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.